Flomoxef

DB11935

small molecule investigational

Deskripsi

Flomoxef has been used in trials studying the treatment of Urinary Tract Infection.

Struktur Molekul 2D

Berat 496.46
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

796 Data
Probenecid The serum concentration of Flomoxef can be increased when it is combined with Probenecid.
Foscarnet The risk or severity of nephrotoxicity can be increased when Flomoxef is combined with Foscarnet.
Mannitol The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Flomoxef.
Tenofovir disoproxil Flomoxef may increase the nephrotoxic activities of Tenofovir disoproxil.
Tenofovir alafenamide Flomoxef may increase the nephrotoxic activities of Tenofovir alafenamide.
Tenofovir Flomoxef may increase the nephrotoxic activities of Tenofovir.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Flomoxef.
Cyclosporine The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Flomoxef.
Icosapent The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Flomoxef.
Cefotiam The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Flomoxef.
Mesalazine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Flomoxef.
Cefmenoxime The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Flomoxef.
Cefmetazole The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Flomoxef.
Indomethacin The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Flomoxef.
Triamterene The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Flomoxef.
Cefpiramide The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Flomoxef.
Loracarbef The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Flomoxef.
Cefalotin The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Flomoxef.
Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Flomoxef.
Ketorolac The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Flomoxef.
Tenoxicam The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Flomoxef.
Celecoxib The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Flomoxef.
Cefotaxime The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Flomoxef.
Tolmetin The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Flomoxef.
Rofecoxib The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Flomoxef.
Fenoprofen The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Flomoxef.
Valdecoxib The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Flomoxef.
Diclofenac The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Flomoxef.
Sulindac The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Flomoxef.
Bacitracin The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Flomoxef.
Amphotericin B The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Flomoxef.
Cephaloglycin The risk or severity of nephrotoxicity can be increased when Cephaloglycin is combined with Flomoxef.
Adefovir dipivoxil The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Flomoxef.
Pentamidine The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Flomoxef.
Mefenamic acid The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Flomoxef.
Naproxen The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Flomoxef.
Sulfasalazine The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Flomoxef.
Phenylbutazone The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Flomoxef.
Meloxicam The risk or severity of methemoglobinemia can be increased when Flomoxef is combined with Meloxicam.
Carprofen The risk or severity of nephrotoxicity can be increased when Carprofen is combined with Flomoxef.
Tacrolimus The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Flomoxef.
Etacrynic acid The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Flomoxef.
Ceforanide The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Flomoxef.
Salicylic acid The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Flomoxef.
Acetylsalicylic acid The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Flomoxef.
Hydrochlorothiazide The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Flomoxef.
Balsalazide The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Flomoxef.
Cefditoren The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Flomoxef.
Atazanavir The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Flomoxef.
Colistimethate The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Flomoxef.
Cefuroxime The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Flomoxef.
Cefapirin The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Flomoxef.
Cefprozil The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Flomoxef.
Olsalazine The risk or severity of nephrotoxicity can be increased when Flomoxef is combined with Olsalazine.
Lumiracoxib The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Flomoxef.
Cefamandole The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Flomoxef.
Cefazolin The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Flomoxef.
Cefonicid The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Flomoxef.
Cefoperazone The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Flomoxef.
Cefoxitin The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Flomoxef.
Ceftizoxime The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Flomoxef.
Magnesium salicylate The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Flomoxef.
Salsalate The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Flomoxef.
Choline magnesium trisalicylate The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Flomoxef.
Cefepime The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Flomoxef.
Cefacetrile The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Flomoxef.
Cefpodoxime The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Flomoxef.
Antrafenine The risk or severity of nephrotoxicity can be increased when Antrafenine is combined with Flomoxef.
Aminophenazone The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Flomoxef.
Antipyrine The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Flomoxef.
Tiaprofenic acid The risk or severity of nephrotoxicity can be increased when Tiaprofenic acid is combined with Flomoxef.
Lopinavir The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Flomoxef.
Etoricoxib The risk or severity of nephrotoxicity can be increased when Etoricoxib is combined with Flomoxef.
Hydrolyzed Cephalothin The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Flomoxef.
Cephalothin Group The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Flomoxef.
Oxyphenbutazone The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Flomoxef.
Latamoxef The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Flomoxef.
Nimesulide The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Flomoxef.
Benoxaprofen The risk or severity of nephrotoxicity can be increased when Benoxaprofen is combined with Flomoxef.
Metamizole The risk or severity of nephrotoxicity can be increased when Metamizole is combined with Flomoxef.
Zomepirac The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Flomoxef.
Ceftobiprole The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Flomoxef.
Cimicoxib The risk or severity of nephrotoxicity can be increased when Cimicoxib is combined with Flomoxef.
Ceftaroline fosamil The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Flomoxef.
Lornoxicam The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Flomoxef.
Zaltoprofen The risk or severity of nephrotoxicity can be increased when Zaltoprofen is combined with Flomoxef.
Azapropazone The risk or severity of nephrotoxicity can be increased when Azapropazone is combined with Flomoxef.
Parecoxib The risk or severity of nephrotoxicity can be increased when Parecoxib is combined with Flomoxef.
Salicylamide The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Flomoxef.
Kebuzone The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Flomoxef.
Isoxicam The risk or severity of nephrotoxicity can be increased when Isoxicam is combined with Flomoxef.
Indoprofen The risk or severity of nephrotoxicity can be increased when Indoprofen is combined with Flomoxef.
Ibuproxam The risk or severity of nephrotoxicity can be increased when Ibuproxam is combined with Flomoxef.
Floctafenine The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Flomoxef.
Fenbufen The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Flomoxef.
Etofenamate The risk or severity of nephrotoxicity can be increased when Etofenamate is combined with Flomoxef.
Epirizole The risk or severity of nephrotoxicity can be increased when Epirizole is combined with Flomoxef.
Cefaloridine The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Flomoxef.
Cefminox The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Flomoxef.
Dexibuprofen The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Flomoxef.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul